Prem Shankar Mishra | Computational Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Prem Shankar Mishra | Computational Biology | Best Researcher Award

Professor & Dean, at Faculty of Pharmacy, Vidya University, India.

Prof. Dr. Prem Shankar Mishra is a distinguished academician, researcher, and administrative leader in the field of Pharmaceutical Sciences. With over 15 years of professional experience, he has excelled in drug design, molecular docking, synthetic chemistry, and formulation development. Currently, he serves as Professor and Dean at Vidya University, Meerut, Uttar Pradesh. Dr. Mishra is known for his dynamic contributions to both academia and research, holding various prestigious positions such as Head of Central Instrumentation Facilities and PCI Inspector. He has published extensively, secured multiple national and international patents, and received significant research grants. His academic leadership extends into accreditations, regulatory affairs, and institutional development. He has received the International Academic Excellence Award 2022 and is widely recognized for his impactful research in anticancer drug discovery, Alzheimer’s therapy, and artificial intelligence applications in pharmacy.

Professional Profile

Education

Dr. Prem Shankar Mishra holds an illustrious academic background that reflects his deep commitment to pharmaceutical sciences. He earned his Ph.D. in Pharmacy, following a Master of Pharmacy (M. Pharm.) in Pharmaceutical Chemistry, and a Bachelor of Pharmacy (B. Pharm.). Complementing his scientific expertise, he also pursued a degree in Law (LLB), making him proficient in legal and regulatory frameworks relevant to the healthcare sector. His academic pursuits are grounded in rigorous research methodologies and an interdisciplinary approach, which integrates drug discovery, analytical chemistry, and legal knowledge. His educational journey empowered him with an extensive understanding of structural elucidation, spectroscopy (IR, NMR, HPLC, UV), and in-silico tools. This solid academic foundation has fueled his ability to contribute to academic excellence, institutional leadership, and cutting-edge scientific research.

Experience

With a professional journey spanning over 15 years, Dr. Mishra has demonstrated excellence in academic instruction, institutional leadership, and research development. He is currently the Dean of the School of Pharmacy at Vidya University, Meerut (since June 2025), and previously served as Professor and Head at Galgotias University (2017-2025). He began his academic career as an Assistant Professor at MIET, Meerut in 2010. His administrative roles include managing NBA and NAAC accreditation processes, leading Central Instrumentation Facilities, and serving as a PCI-approved Inspector. Dr. Mishra is also experienced in ISO certification protocols (ISO 9001:2015, ISO 17025:2017). His visionary leadership is evident in establishing research labs, fostering industry collaborations, and promoting a research-centric academic environment. His dynamic mentoring style and academic initiatives have empowered students and faculty alike, enriching the pharmaceutical education ecosystem.

Research Interests

Dr. Mishra’s research interests lie in drug design, heterocyclic synthesis, anticancer compounds, and pharmaceutical formulation development. His work spans synthetic and natural compounds, structural elucidation, and pharmacological evaluation. Notably, he has conducted extensive research in computer-aided drug design, de novo drug development, and in-vitro/in-vivo biological evaluations including anti-diabetic, anticancer, and antimicrobial assays. He has contributed significantly to the development of herbal formulations, nanoemulgels, biosensors, and mobile healthcare apps. His technical expertise also includes chromatographic method validation (HPLC, HPTLC, LC-MS), cytotoxicity assays (FACS, MTT, ROS generation), and molecular docking simulations. He has received multiple patents in India and abroad, especially in drug delivery and diagnostic device innovation. Dr. Mishra continues to push boundaries in translational pharmaceutical research that bridges laboratory discoveries with clinical applications.

Awards & Honors

Dr. Mishra has been recognized with numerous accolades that celebrate his academic and research excellence. Most notably, he received the International Academic Excellence Award 2022 at the Global Edu-Conclave. He is a recipient of competitive research grants, including Rs. 0.5 lakh each from the Council of Science and Technology (UP) and DRDO for organizing national scientific conferences. His credibility as an innovator is also evidenced by multiple national and international patent grants. Additionally, he holds leadership roles in institutional development, notably as a core team member for NAAC and NBA accreditation. His patents span biosensor technologies, nanoemulgels, anticancer formulations, and healthcare apps. These accomplishments underscore his dedication to innovation, policy, pedagogy, and scientific advancement, earning him a well-regarded status in the pharmaceutical academia and industry.

Top Noted Publications

Dr. Mishra has authored over 35 peer-reviewed publications in reputed international journals, covering diverse areas such as oncology, neurodegeneration, pharmacognosy, and pharmaceutical technology. Selected recent articles include:

1. Comprehensive Review on Alzheimer’s Disease: Natural Therapeutics, Gaps, and Challenges

  • Year: 2025

2. Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential

  • Year: 2025

3. AI-Assisted Immunology for Precision Cancer Medicine

  • Year: 2025

4. In-silico Screening and Synthesis of Benzo[c]Pyridazines Targeting N-Methyl D-Aspartate Glutamate Receptor for the Treatment of Seizures

  • Year: 2025

5. Novel 2-Pyridone Analogs with Anti-Cancer Activity: Synthesis, In silico, and In vitro Evaluation

  • Year: 2024

6. Role of Natural Secondary Metabolites as HIF-1 Inhibitors in Cancer Therapy

  • Year: 2024

Conclusion

Prof. Dr. Prem Shankar Mishra is an exceptionally qualified and highly deserving candidate for the Best Researcher Award. His prolific output in terms of peer-reviewed articles, awarded patents, leadership in pharmaceutical education, and recognized excellence through grants and awards reflect a sustained commitment to impactful research. With minor enhancements in global networking and translational research application, he could further amplify his scholarly legacy. Nonetheless, his current academic and research contributions already place him in the top tier of pharmaceutical science researchers.

Xiaoqiang Chang | Molecular Medicine | Best Research Article Award

Published on by Molecular Biologist

Dr. Xiaoqiang Chang | Molecular Medicine | Best Research Article Award 

Doctorate, at School of Pharmacy, China.

Dr. Xiaoqiang Chang (常小强) is a dedicated pharmaceutical researcher currently serving at the School of Pharmacy, Bengbu Medical College (蚌埠医科大学). He earned his Ph.D. and Master’s degrees in Traditional Chinese Pharmacy from the China Academy of Chinese Medical Sciences, and his Bachelor’s from Henan University of Chinese Medicine. His research is focused on innovative methodologies in medicinal compound synthesis, particularly in the field of natural products and green catalysis. With notable publications in Environmental Chemistry Letters, Advanced Synthesis & Catalysis, and Molecules, he has proven his expertise as a unique first author. His academic journey reflects a consistent commitment to advancing pharmaceutical sciences, combining electrochemical, chromatographic, and synthetic techniques to explore medicinal compounds. Dr. Chang also holds a Chinese patent on diphenyldiazepine derivatives. His contributions continue to bridge traditional Chinese medicine with modern pharmaceutical innovation. 🌿⚗️📚

Professional Profile

ORCID

🎓 Education 

Dr. Xiaoqiang Chang’s academic foundation is deeply rooted in Traditional Chinese Medicine. He began his journey at Henan University of Chinese Medicine (2013-2017), earning a Bachelor’s degree in Pharmaceutical Preparation of Traditional Chinese Medicine. Driven by a passion for scientific research, he pursued graduate studies at the prestigious China Academy of Chinese Medical Sciences, obtaining a Master’s degree (2017-2020) and then a Doctorate in Chinese Pharmacy (2020-2023). During his doctoral training, Dr. Chang focused on natural product chemistry and drug development, incorporating both ancient medicinal knowledge and modern synthetic chemistry. His academic track equipped him with cross-disciplinary skills in chromatography, catalysis, and compound synthesis. His research is characterized by a fusion of heritage and innovation, reinforcing the relevance of traditional medicine in contemporary pharmaceutical sciences. 🎓🔬📖

💼 Experience 

Dr. Chang began his professional research career as an Assistant Researcher at the Henan Academy of Sciences, specifically at the Biomass Pyrolysis Transformation Innovation Center (July 2023 – May 2024). Here, he investigated catalytic processes for converting biomass into pharmacologically active compounds, applying both chemical engineering and pharmaceutical expertise. In June 2024, he joined the School of Pharmacy, Bengbu Medical College, further expanding his work in drug development and compound synthesis. His transition from biomass research to pharmaceutical innovation reflects his versatile research capabilities. Despite not having postdoctoral experience, Dr. Chang has successfully led multiple projects and published extensively. His roles have not only included laboratory research but also academic mentorship and interdisciplinary collaboration, making him a rising figure in applied pharmaceutical sciences. 🔍🏥🧪

🔬 Research Interest 

Dr. Chang’s research interest lies at the intersection of natural product chemistry, electrochemical synthesis, and green pharmaceutical technology. He is particularly intrigued by boron-catalyzed hydrosulfonylation, [3+2] electrochemical cycloaddition, and chromatographic techniques for active compound analysis. His recent work has focused on discovering and optimizing synthesis routes for medicinally relevant heterocycles and sulfones. Dr. Chang is passionate about developing sustainable and selective synthetic pathways, aiming to minimize environmental impact while maximizing pharmaceutical efficacy. In addition, his background in Traditional Chinese Medicine enriches his understanding of herbal pharmacology, leading to a unique integration of ancient wisdom and modern methodology. This cross-disciplinary approach is evident in both his experimental design and publication record. His long-term vision is to establish eco-friendly, high-efficiency platforms for drug discovery from both synthetic and natural sources. 🌱🧬⚙️

🏆 Awards 

Although Dr. Chang has yet to receive national-level funding or formal academic awards, his contribution to pharmaceutical research has been formally recognized through intellectual property achievements. In June 2023, he co-authored a Chinese patent titled “二苯并二氮杂卓衍生物及其制备方法和应用” (Diphenyldiazepine derivatives and their preparation method and application), registered as CN202310743034.9. This patent underscores his ability to transition basic chemical findings into practical applications, a key metric in modern pharmaceutical evaluation. The novelty and application potential of the compound structure demonstrate both innovation and therapeutic foresight. While still early in his career, Dr. Chang’s consistent authorship as the sole first author across several high-impact journal articles signifies his scientific independence and leadership. His continued work promises future recognition and contributions to medical chemistry and drug discovery. 🧪📜🚀

📚 Top Noted Publications 

1.Title: Synthesis of branched allylic sulfones by regioselective boron-catalysed hydrosulfonylation
Journal: Environmental Chemistry Letters
Year: 2023
Volume: 21
Pages: 681–687
Citations: 7
Summary:
This paper reports a novel method for synthesizing branched allylic sulfones using a regioselective boron-catalyzed hydrosulfonylation reaction. The methodology showcases high efficiency and selectivity, contributing significantly to sustainable synthetic chemistry and green catalysis.

2.Title: Electrochemical [3+2] Cycloaddition of Anilines and 1,3‐Dicarbonyl Compounds
Journal: Advanced Synthesis & Catalysis
Year: 2022
Volume: 364(16)
Pages: 2865–2871
Citations: 12
Summary:
This article presents an electrochemical approach for [3+2] cycloaddition between anilines and 1,3-dicarbonyl compounds. It demonstrates a metal-free and environmentally friendly route, offering a valuable synthetic tool in heterocyclic chemistry.

3.Title: A novel flavanone from Thymus przewalskii
Journal: China Journal of Chinese Materia Medica (中国中药杂志)
Year: 2021
Volume: 46(1)
Pages: 125–129
Citations: 4
Summary:
This study details the isolation and structural elucidation of a new flavanone compound from Thymus przewalskii. The findings enhance understanding of the phytochemistry of traditional Chinese medicinal herbs.

4.Title: Determination of Thymol and Carvacrol in Thymi herba by UPC2
Journal: Molecules
Year: 2020
Volume: 25
Article Number: 502
Citations: 16
Summary:
This paper describes a fast and reliable ultra-performance convergence chromatography (UPC2) method to quantify thymol and carvacrol in Thymi herba. It is significant for quality control in herbal medicine and pharmaceutical applications.

5.Title: 地椒质量标准的研究 (Study on the Quality Standards of Di Jiao)
Journal: 中成药 (Chinese Patent Medicine)
Year: 2019
Volume: 41(8)
Pages: 1894–1898
Citations: 5
Summary:
This article explores the establishment of quality control standards for Di Jiao (地椒), a traditional Chinese medicinal material. It involves pharmacognostic and chemical evaluation techniques to ensure consistency and efficacy.

Conclusion

Dr. Xiaoqiang Chang demonstrates clear scientific excellence, with a consistent track record of innovative, independently-led publications in high-impact journals and contribution to intellectual property development. While additional involvement in research grants and broader academic leadership would strengthen the application, his current scholarly output makes him highly competitive for the Best Research Article Award. His first-author articles reflect originality, depth, and relevance—hallmarks of an outstanding candidate.